PCG
ARNA

Private Capital Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Private Capital Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-135
Closed -$13K – 2244
2021
Q4 		$13K Buy
135
+1
+0.7% +$66 ﹤0.01% 1226
2021
Q3 		$8K Sell
134
-166
-55% -$9.8K ﹤0.01% 1438
2021
Q2 		$21K Hold
300
– – ﹤0.01% 1080
2021
Q1 		$21K Sell
300
-100
-25% -$7.7K 0.01% 1057
2020
Q4 		$31K Sell
400
-3
-0.7% -$225 0.01% 1006
2020
Q3 		$30K Buy
403
+4
+1% +$267 0.01% 947
2020
Q2 		$25K Sell
399
-12
-3% -$660 0.01% 1016
2020
Q1 		$17K Buy
411
+351
+585% +$16.1K ﹤0.01% 1100
2019
Q4 		$2K Buy
60
+38
+173% +$1.8K ﹤0.01% 1745
2019
Q3 		$1K Buy
+22
New +$1.24K ﹤0.01% 2136

Private Capital Group's ARNA Position: Q1 2022 in Review

Private Capital Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 135 shares — an estimated $13K sold.

Private Capital Group first reported a position in ARNA in Q3 2019 and held it in 10 quarters. The position peaked at $31K in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Private Capital Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Private Capital Group sold 135 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $13K.
  • Private Capital Group first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 10 quarters.
  • Private Capital Group's Arena Pharmaceuticals Inc position peaked at $31K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Private Capital Group's 13F filing for Q1 2022, filed 21 Apr 2022.